← Leaderboards
Michael H. Cho
Brigham And Women'S Hospital
$16,257,579
Attributed
$30,835,164
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,835,164 · 11
By mechanism
R01$30,286,726 · 10
K08$548,438 · 1
Top collaborators
- Edwin K Silverman13 shared
- Anny Xiaobo Zhou9 shared
- Gary Matthew Hunninghake6 shared
- Ani Wang Manichaikul5 shared
- Alejandro Diaz4 shared
- Hae Kyung Im1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Alejandro Diaz$8,782,808
- Edwin K Silverman$89,199,838
- Joann Elisabeth Manson$50,755,529
- Gary Matthew Hunninghake$13,432,772
- Anny Xiaobo Zhou$14,633,236
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticGenome Wide Association StudyGenesPathogenesisLungGenetic VariantGenome-WideBiologicalVariantGene ExpressionPhenotypeBaseGenomicsMolecularStructure Of Parenchyma Of LungInsightWhole GenomePathway InteractionsAffectCohortDisorder RiskCellsMortalityCigarette Smoking
Grant awards (38)
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$1,542,983
R01 · FY2025 · HL
Interrogating the pathogenesis of COPD using metabolomics and genomics data$800,679
R01 · FY2025 · HL
Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosis$774,616
R01 · FY2025 · HL · contact PI
Identifying Subtypes of COPD Using Metabolomic and Genomic Approaches$697,642
R01 · FY2025 · HL · contact PI
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$1,489,128
R01 · FY2024 · HL
Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosis$743,814
R01 · FY2024 · HL · contact PI
Identifying Subtypes of COPD Using Metabolomic and Genomic Approaches$737,142
R01 · FY2024 · HL · contact PI
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A$654,053
R01 · FY2024 · HL · contact PI
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$606,652
R01 · FY2024 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers$818,818
R01 · FY2023 · HL
Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosis$781,643
R01 · FY2023 · HL · contact PI
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$650,695
R01 · FY2023 · HL
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$882,588
R01 · FY2022 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers$818,818
R01 · FY2022 · HL
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$758,323
R01 · FY2022 · HL
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$887,786
R01 · FY2021 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers$818,818
R01 · FY2021 · HL
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$768,999
R01 · FY2021 · HL
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$886,191
R01 · FY2020 · HL
Identifying functional variants in COPD GWAS loci$848,038
R01 · FY2020 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$800,376
R01 · FY2020 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers$714,886
R01 · FY2020 · HL
Identifying functional variants in COPD GWAS loci$886,769
R01 · FY2019 · HL
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$886,191
R01 · FY2019 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$843,606
R01 · FY2019 · HL
Identifying functional variants in COPD GWAS loci$877,981
R01 · FY2018 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$669,110
R01 · FY2018 · HL
Identifying functional variants in COPD GWAS loci$853,683
R01 · FY2017 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$787,403
R01 · FY2017 · HL
Identifying Genetic Determinants of Severe, Early-Onset COPD$1,027,014
R01 · FY2016 · HL
Identifying Genetic Determinants of Severe, Early-Onset COPD$1,007,670
R01 · FY2015 · HL
Identifying Genetic Determinants of Severe, Early-Onset COPD$949,777
R01 · FY2014 · HL
Identifying Genetic Determinants of Severe, Early-Onset COPD$2,379,783
R01 · FY2013 · HL
Approaches to Identify Rare and Common Genetic Determinants in Severe COPD$137,160
K08 · FY2013 · HL · contact PI
Identifying Genetic Determinants of Severe, Early-Onset COPD$635,051
R01 · FY2012 · HL
APPROACHES TO IDENTIFY RARE AND COMMON GENETIC DETERMINANTS IN SEVERE COPD$137,160
K08 · FY2012 · HL · contact PI
APPROACHES TO IDENTIFY RARE AND COMMON GENETIC DETERMINANTS IN SEVERE COPD$137,160
K08 · FY2011 · HL · contact PI
APPROACHES TO IDENTIFY RARE AND COMMON GENETIC DETERMINANTS IN SEVERE COPD$136,958
K08 · FY2010 · HL · contact PI